|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
ACT 101 Human Safety in Clinical Research
Pharmaceutical companies must pay close attention to the safety of human subjects at every stage of drug development, as explained in this QA view of the policies and regulations that make the system work.
Advertisement
Articles in this issue
over 24 years ago
Letters to the Editorover 24 years ago
Conference Reportsover 24 years ago
Affairs of Stateover 24 years ago
Pen-Based Computingover 24 years ago
Some Do--Some Watch Over Those Who Doover 24 years ago
Communication Skills for Monitors—A Vital Training OpportunityNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
3
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
4
Rethinking Operational Models to Reduce Site Burden in 2026
5